Results 71 to 80 of about 3,400,910 (254)

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Dataset of the dose distributions in patients with stage I non-small lung cancer receiving passive scattering carbon ion radiotherapy

, 2020
This database includes the daily and accumulated dose distributions in patients with lung cancer receiving hypofractionated carbon-ion ...
li, Y
core   +2 more sources

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Carbon ion radiotherapy for chondrosarcoma

Carbon ion radiotherapy for chondrosarcoma
Purpose: Chondrosarcoma is the second most frequent primary malignant bone tumor. Surgery has been considered as the main form of treatment for chondrosarcoma, and the definitive en bloc resection of tumor is mandatory to obtain long term disease free survival. However, radical surgical intervention has been associated with substantial morbidities. Due
openaire   +4 more sources

Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801)

Frontiers in Oncology, 2019
Background and purpose: Favorable clinical outcomes of carbon-ion radiotherapy for pelvic recurrence of rectal cancer have been described by previous prospective phase I/II and II studies; however, these studies were performed at a single institution ...
Shintaro Shiba, Shintaro Shiba, Masahiko Okamoto, Hiroki Kiyohara, Tatsuya Ohno, Takuya Kaminuma, Takayuki Asao, Hitoshi Ojima, Ken Shirabe, Hiroyuki Kuwano, Takashi Nakano   +10 more
doaj   +1 more source

Overview of Carbon-ion Radiotherapy

Journal of Physics: Conference Series, 2017
The outcome of radiotherapy depends on potential efficiency of accelerators and their related accessories. In charged particle therapy before the 1990s, accelerators that were primarily installed for physics research had been shared, which however had limited flexibility for clinical use.
openaire   +1 more source

Overview of Carbon Ion Radiotherapy

, 2012
In cancer radiotherapy (RT), ion beams such as proton and carbon ion beams have unique characteristics of improved dose distributions, enabling a delivery of sufficient dose to the target volume while minimizing the dose in the surrounding normal tissues.
Tsujii, Hirohiko, 636024, 636023, 636505, 辻井 博彦, 636506   +5 more
core  

Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report [PDF]

, 2013
Recurrences of cervical cancer after definitive radiotherapy often occur at common iliac or para-aortic lymph nodes as marginal lymph node recurrences.
Shin-ei Noda, Ken Ando, Yu Ohkubo, Kiyohara, Hiroki, Tamaki, Tomoaki, Tatsuya Ohno, Tomoaki Tamaki, Kato, Shingo, Ohno, Tatsuya, Nakano, Takashi, Wakatsuki, Masaru, Shingo Kato, Kamada, Tadashi, Tadashi Kamada, Noda, Shin-ei, Ohkubo, Yu, Takashi Nakano, Hiroki Kiyohara, Ando, Ken, Masaru Wakatsuki   +19 more
core   +1 more source

Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma

, 2022
Carbon-ion radiotherapy (C-ion RT) has shown potential as a curative treatment for patients with hepatocellular carcinoma (HCC). However, no reports have compared the effectiveness of C-ion RT and radiofrequency ablation (RFA).
Hiroaki Kanzaki, Naoya Kato, Yoshihiro Koma, Soichiro Kiyono, Yotaro Iino, Jun Kato, Naoto Fujita, Susumu Maruta, Tetsuhiro Chiba, Yuki Shiko, Sadahisa Ogasawara, Keisuke Koroki, Ryosaku Azemoto, Hirokazu Makishima, Masato Nakamura, Kazufumi Kobayashi, Shingo Nakamoto, Hiroshi Tsuji, Masamichi Obu, Naoya Kanogawa, Yohei Kawasaki, Ei Itobayashi, Takayuki Kondo, Masaru Wakatsuki   +23 more
core   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source